Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial

Diabetic Medicine

Volumn 30, Issue 12, 2013, Pages 1477-1481

  Salehpour, A ^a   Shidfar, F ^a   Hosseinpanah, F ^b   Vafa, M ^a   Razaghi, M ^a   Amiri, F ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PLACEBO;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CALCIUM INTAKE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FAT INTAKE; FEMALE; FOOD COMPOSITION; FOOD FREQUENCY QUESTIONNAIRE; GLUCOSE HOMEOSTASIS; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ION EXCHANGE; MAJOR CLINICAL STUDY; METABOLIC EQUIVALENT; NUTRIENT CONTENT; NUTRITIONAL ASSESSMENT; OBESITY; PHYSICAL ACTIVITY; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLECALCIFEROL; DIET RECORDS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EATING; EXERCISE; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; QUESTIONNAIRES; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84887623061     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12273     Document Type: Article

References (24)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353-373.
3. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002; 9: 87-98.
4. Grundy SM. A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor. Euro Heart J Suppl 2008; 10: B16-23.
5. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006; 29: 2244-2246.
6. Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D et al. Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 2011; 96: 1320-1326.
7. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94: 209-217.
8. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
9. Mitri J, Muraru MD, Pittas AG . Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65: 1005-1015.
10. WHO. Physical Status: The Use and Interpretation of Anthropometry. Technical Report Series No. 854. Geneva: World Health Organization, 1995.
11. Hosseini Esfahani F, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran lipid and glucose study. J Epidemiol 2010; 20: 150-158.
12. Azar M, Sarkisian E. Food Composition Table of Iran. Tehran: National Nutrition and Food Research Institute, Shaheed Beheshti University, 1980.
13. Ars.usda.gov. Homepage on Internet. Washington DC: United States Department of Agriculture, Agriculture of Research Service. Updated 27 April 2009. Available at http://www.nal.usda.gov/fnic/foodcomp.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β-cell function, insulin sensitivity and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-494.
16. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with pre-diabetes and hypovitaminosis D. Diabetes Care 2012; 35: 1-7.
17. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-1327.
18. Major GC, Alarie F, Doré J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007; 85: 54-59.
19. Forouhi N G, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance. Diabetes 2008; 57: 2619-2625.
20. Bourlon PM, Faure-Dussert AG, Billaudel BJ. Modulatory role of 1, 25-dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat. Br J Pharmacol 1997; 121: 751-758.
21. Reusch JE, Begum N, Sussman KE, Draznin B. Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology 1991; 129: 3269-3273.
22. Maestro B. Stimulation by 1, 25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000; 47: 383-391.
23. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012; 29: e142-e150.
24. Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A et al. Vitamin D deficiency: a new risk factor for Type 2 diabetes? Ann Nutr Metab 2012; 61: 337-348.